Kurosh Gharagozli - Concepedia

Author

Kurosh Gharagozli

Shahid Beheshti University of Medical Sciences

Also Known As

Gharagozli K, Gharagozli, Kurosh, K Gharagozli, K. Gharagozli, Kourosh Gharagozli, Kourosh Gharagozli, Kurosh Gharagozli

Publications

372

Citations

H-Index

Concepts

All Affiliations

Shahid Beheshti University of Medical Sciences Tabriz University of Medical Sciences University of Otago National Institute of Genetic Engineering and Biotechnology University of Nicosia

About

Kurosh Gharagozli is an author at Shahid Beheshti University of Medical Sciences specializing in neurology, medicine, and multiple sclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	89
2	Immunology	2	2	27
3	Public Health	1	1	20
4	Social Sciences	1	1	24
5	Epidemiology	1	1	20

Kurosh Gharagozli

Publications

302

Citations

H-Index

Page 1

	Year	Citations
Multiple sclerosis: report on 200 cases from Iran Hossein Kalanie, Kurosh Gharagozli, Amir Reza Kalanie Multiple Sclerosis Journal	2003	54
The burden of Parkinson’s disease in the Middle East and North Africa region, 1990–2019: results from the global burden of disease study 2019 Saeid Safiri, Maryam Noori, Seyed Aria Nejadghaderi, BMC Public Health	2023	52
Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial. Kurosh Gharagozli, Ali Amini Harandi, Sina Houshmand, PubMed	2018	44
Do Haplogroups H and U Act to Increase the Penetrance of Alzheimer’s Disease? Farzaneh Fesahat, Massoud Houshmand, Mehdi Shafa Shariat Panahi, Cellular and Molecular Neurobiology Neurodegenerative DiseasesGeriatric NeurologyAlzheimer's DiseaseHaplogroups HMedicine	2006	42
Two predictors of postictal generalized EEG suppression: Tonic phase duration and postictal immobility period Marjan Asadollahi, Mahyar Noorbakhsh, Leila Simani, Seizure Postictal Immobility PeriodNeuropsychologyNeuropsychological FunctioningNeurophysiologyEeg Signal Processing	2018	24
Mitochondrial D-Loop Variation in Persian Multiple Sclerosis Patients: K and A Haplogroups as a Risk Factor!! Hassan Hassani Kumleh, Massoud Houshmand, Mehdi Shafa Shariat Panahi, Cellular and Molecular Neurobiology Neurodegenerative DiseasesA HaplogroupsAmyotrophic Lateral SclerosisNeurological DisorderNeuroepidemiology	2006	20
The burden of Alzheimer’s disease and other types of dementia in the Middle East and North Africa region, 1990–2019 Saeid Safiri, Maryam Noori, Seyed Aria Nejadghaderi, Age and Ageing	2023	18
Thioredoxin-1, redox factor-1 and thioredoxin-interacting protein, mRNAs are differentially expressed in Multiple Sclerosis patients exposed and non-exposed to interferon and immunosuppressive treatments Elham Mahmoudian, Ahad Khalilnezhad, Kurosh Gharagozli, Gene InflammationCytokineMultiple Sclerosis PatientsAutoimmune DiseaseThioredoxin-interacting Protein	2017	17
Newer antiepileptic drugs discontinuation due to adverse effects: An observational study Kurosh Gharagozli Annals of Indian Academy of Neurology	2018	11
Interferon Beta-1a and Intravenous Immunoglobulin Treatment for Multiple Sclerosis in Iran Hossein Kalanie, Kurosh Gharagozli, Abolfazl Hemmatie, European Neurology Autoimmune DiseaseSystemic SclerodermaIntravenous ImmunoglobulinImmunodeficienciesImmunology	2004	10

Page 1